加速康复外科理念在减少胃癌手术应激反应中的应用与进展

doi:10.3760/cma.j.issn.1673-422X.2020.03.011

国际肿瘤学杂志 ›› 2020, Vol. 47 ›› Issue (3): 185-189.doi: 10.3760/cma.j.issn.1673-422X.2020.03.011

加速康复外科理念在减少胃癌手术应激反应中的应用与进展

陈邦^1,², 陈博^1,²()

¹ 安徽医科大学研究生院,合肥 230022;
² 安徽医科大学第一附属医院胃肠外科,合肥 230022

收稿日期:2019-09-06 修回日期:2019-10-07 出版日期:2020-03-08 发布日期:2020-05-27
通讯作者: 陈博 E-mail:chenbo831116@163.com
基金资助:
国家自然科学基金(81602425)

Application and progress of the concept of enhanced recovery after surgery in reducing surgical stress response in gastric cancer

Chen Bang^1,², Chen Bo^1,²()

¹ Graduate School of Anhui Medical University, Hefei 230022, China;
² Department of Gastrointestinal Surgery, First Affiliated Hospital of Anhui Medical University, Hefei 230022, China

Received:2019-09-06 Revised:2019-10-07 Online:2020-03-08 Published:2020-05-27
Contact: Chen Bo E-mail:chenbo831116@163.com
Supported by:
National Natural Science Foundation of China(81602425)

摘要/Abstract

摘要：

随着加速康复外科(ERAS)理念及路径的深入发展以及相关研究证实其有效性和可行性,ERAS在临床实践中得到了更广泛的应用。近年来研究表明,ERAS逐渐应用于胃肠外科,通过诊疗方案的最优化,包括术前准备、麻醉方案、手术方式、术后康复等,在围手术期可一定程度提升胃癌患者的临床诊疗效果,降低手术风险,且在减少术后应激反应中发挥重要作用。为加快胃癌术后恢复速度,ERAS已引起人们的高度关注。

关键词: 胃肿瘤, 康复, 最小侵入性外科手术, 手术应激反应

Abstract:

With the further development of the concept and path of enhanced recovery after surgery (ERAS) and the confirmation of its effectiveness and feasibility in relevant studies, it has been more widely used in clinical practice. In recent years, studies have shown that ERAS is gradually applied in gastrointestinal surgery. By optimizing the diagnosis and treatment program, including preoperative preparation, anesthesia scheme, surgical procedure and postoperative rehabilitation, etc., in the perioperative period of gastric cancer, ERAS can improve the clinical diagnosis and treatment of gastric cancer patients to a certain extent, reduce the operation risk, and play an important role in reducing the postoperative stress reaction. ERAS has attracted great attention in order to accelerate the recovery of gastric cancer after surgery.

Key words: Stomach neoplasms, Rehabilitation, Minimally invasive surgical procedures, Surgical stress response

陈邦, 陈博. 加速康复外科理念在减少胃癌手术应激反应中的应用与进展[J]. 国际肿瘤学杂志, 2020, 47(3): 185-189.

Chen Bang, Chen Bo. Application and progress of the concept of enhanced recovery after surgery in reducing surgical stress response in gastric cancer[J]. Journal of International Oncology, 2020, 47(3): 185-189.

参考文献 30

[1]	Bray F, Ferlay J, Soerjomataram I , et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424. DOI: 10.3322/caac.21492. doi: 10.3322/caac.v68.6
[2]	Kehlet H . Multimodal approach to control postoperative pathophysiology and rehabilitation[J]. Br J Anaesth, 1997,78(5):606-617. DOI: 10.1093/bja/78.5.606. doi: 10.1093/bja/78.5.606
[3]	黎介寿 . 对Fast-track surgery内涵的认识[J]. 中华普外科手术学杂志(电子版), 2007,1(1):1-2.
[4]	中国加速康复外科专家组. 中国加速康复外科围手术期管理专家共识(2016)[J]. 中华外科杂志, 2016,54(6):413-418. DOI: 10.3760/cma.j.issn.0529-5815.2016.06.004.
[5]	田孝东, 杨尹默 . 理念更新引领行为进步:《加速康复外科中国专家共识及路径管理指南(2018版)》外科部分解读[J]. 协和医学杂志, 2018,9(6):485-489. DOI: 10.3969/j.issn.1674-9081.2018.06.002.
[6]	Fumagalli Romario U, Weindelmayer J, Coratti A , et al. Enhanced recovery after surgery in gastric cancer: which are the main achievements from the Italian experience?[J]. Updates Surg, 2018,70(2):257-264. DOI: 10.1007/s13304-018-0522-8. doi: 10.1007/s13304-018-0522-8
[7]	Sugisawa N, Tokunaga M, Makuuchi R , et al. A phase Ⅱ study of an enhanced recovery after surgery protocol in gastric cancer surgery[J]. Gastric Cancer, 2016,19(3):961-967. DOI: 10.1007/s10120-015-0528-6. doi: 10.1007/s10120-015-0528-6
[8]	Tanaka R, Lee SW, Kawai M , et al. Protocol for enhanced recovery after surgery improves short-term outcomes for patients with gastric cancer: a randomized clinical trial[J]. Gastric Cancer, 2017,20(5):861-871. DOI: 10.1007/s10120-016-0686-1. doi: 10.1007/s10120-016-0686-1
[9]	Ji W, Chandoo A, Guo X , et al. Enhanced recovery after surgery decreases intestinal recovery time and pain intensity in patients undergoing curative gastrectomy[J]. Cancer Manag Res, 2018,10:3513-3520. DOI: 10.2147/CMAR.S168909. doi: 10.2147/CMAR
[10]	Bu J, Li N, Huang X , et al. Feasibility of fast-track surgery in elderly patients with gastric cancer[J]. J Gastrointest Surg, 2015,19(8):1391-1398. DOI: 10.1007/s11605-015-2839-7. doi: 10.1007/s11605-015-2839-7
[11]	Kun L, Tang L, Wang J , et al. Effect of combined general/epidural anesthesia on postoperative NK cell activity and cytokine response in gastric cancer patients undergoing radical resection[J]. Hepatogastroenterology, 2014,61(132):1142-1147. DOI: 10.5754/hge13591.
[12]	Jiang A, Chen LJ, Wang YX , et al. The effects of different methods of anaesthesia for laparoscopic radical gastrectomy with monitoring of entropy[J]. Anticancer Res, 2016,36(3):1305-1308.
[13]	Jiang A, Zhao H, Liu X , et al. Comparison of different muscle-relaxant anesthetics on growth, migration and invasion of gastric cancer cells[J]. Anticancer Res, 2017,37(8):4371-4378. DOI: 10.21873/anticanres.11831.
[14]	Enomoto LM, Blackham A, Woo Y , et al. Ratio of intra-operative fluid to anesthesia time and its impact on short term perioperative outcomes following gastrectomy for cancer: a retrospective cohort study[J]. Int J Surg, 2016,33 Pt A:13-17. DOI: 10.1016/j.ijsu.2016.07.006.
[15]	Sugimachi K, Kitano S, Iso Y , et al. Laparoscopy-assisted Billroth Ⅰ gastrectomy[J]. Surg Laparosc Endosc, 1994,4(2):146-148.
[16]	余佩武, 郝迎学 . 微创技术在中国胃癌手术中应用的历史与发展趋势[J]. 中华胃肠外科杂志, 2016,19(8):846-849. DOI: 10.3760/cma.j.issn.1671-0274.2016.08.002.
[17]	Pędziwiatr M, Matłok M, Kisialeuski M , et al. Enhanced recovery (ERAS) protocol in patients undergoing laparoscopic total gastrectomy[J]. Wideochir Inne Tech Maloinwazyjne, 2014,9(2):252-257. DOI: 10.5114/wiitm.2014.43076.
[18]	Zhou J, He Q, Wang J , et al. Application of enhanced recovery after surgery in single-incision laparoscopic distal gastrectomy[J]. Surg Laparosc Endosc Percutan Tech, 2017,27(6):449-455. DOI: 10.1097/SLE.0000000000000474.
[19]	Liu XX, Pan HF, Jiang ZW , et al. "Fast-track" and "minimally invasive" surgery for gastric cancer[J]. Chin Med J (Engl), 2016,129(19):2294-2300. DOI: 10.4103/0366-6999.190659.
[20]	李益萍, 邱江锋, 曹晖 . 加速康复外科在腹腔镜胃癌根治术围手术期中的应用[J]. 中华胃肠外科杂志, 2016,19(3):269-273. DOI: 10.3760/cma.j.issn.1671-0274.2016.03.009.
[21]	Desiderio J, Stewart CL, Sun V , et al. Enhanced recovery after surgery for gastric cancer patients improves clinical outcomes at a US cancer center[J]. J Gastric Cancer, 2018,18(3):230-241. DOI: 10.5230/jgc.2018.18.e24. doi: 10.5230/jgc.2018.18.e24
[22]	Aoyama T, Yoshikawa T, Sato T , et al. Equivalent feasibility and safety of perioperative care by ERAS in open and laparoscopy-assisted distal gastrectomy for gastric cancer: a single-institution ancillary study using the patient cohort enrolled in the JCOG0912 phase Ⅲ trial[J]. Gastric Cancer, 2019,22(3):617-623. DOI: 10.1007/s10120-018-0873-3. doi: 10.1007/s10120-018-0873-3
[23]	King AB, Spann MD, Jablonski P , et al. An enhanced recovery program for bariatric surgical patients significantly reduces perioperative opioid consumption and postoperative nausea[J]. Surg Obes Relat Dis, 2018,14(6):849-856. DOI: 10.1016/j.soard.2018.02.010. doi: 10.1016/j.soard.2018.02.010
[24]	周岩冰 . 加速康复外科时代机器人胃癌外科[J]. 中华胃肠外科杂志, 2017,20(5):495-499. DOI: 10.3760/cma.j.issn.1671-0274.2017.05.003.
[25]	Zhao J, Hu J, Jiang Z , et al. Outcome of discharge within 72 hours of robotic gastrectomy using enhanced recovery after surgery programs[J]. J Laparoendosc Adv Surg Tech A, 2018,28(11):1279-1286. DOI: 10.1089/lap.2018.0051. doi: 10.1089/lap.2018.0051
[26]	丛霆, 刘国晓, 张珂诚 , 等. 机器人和腹腔镜辅助根治性全胃切除术在体质指数高于正常值胃癌患者中的应用[J]. 中华胃肠外科杂志, 2018,21(3):318-324. DOI: 10.3760/cma.j.issn.1671-0274.2018.03.015.
[27]	Makuuchi R, Sugisawa N, Kaji S , et al. Enhanced recovery after surgery for gastric cancer and an assessment of preoperative carbohydrate loading[J]. Eur J Surg Oncol, 2017,43(1):210-217. DOI: 10.1016/j.ejso.2016.07.140. doi: 10.1016/j.ejso.2016.07.140
[28]	Shao L, Pang N, Yan P , et al. Control of body temperature and immune function in patients undergoing open surgery for gastric cancer[J]. Bosn J Basic Med Sci, 2018,18(3):289-296. DOI: 10.17305/bjbms.2018.2552. doi: 10.17305/bjbms.2018.2552
[29]	Tweed T, van Eijden Y, Tegels J , et al. Safety and efficacy of early oral feeding for enhanced recovery following gastrectomy for gastric cancer: a systematic review[J]. Surg Oncol, 2019,28:88-95. DOI: 10.1016/j.suronc.2018.11.017. doi: 10.1016/j.suronc.2018.11.017
[30]	吴棠, 杨露 . 胃癌术后四君子汤联合营养支持对应激炎症反应、免疫应答反应的影响[J]. 海南医学院学报, 2018,24(6):696-699. DOI: 10.13210/j.cnki.jhmu.20180403.010.

加速康复外科理念在减少胃癌手术应激反应中的应用与进展

Application and progress of the concept of enhanced recovery after surgery in reducing surgical stress response in gastric cancer

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 30

相关文章 15

编辑推荐

Metrics

本文评价

[1]	袁健, 黄燕华. Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[2]	杨琳, 路宁, 温华, 张明鑫, 朱琳. 炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[3]	解淑萍, 孙亚红, 汪超. 早期肿瘤标志物联合NLR、PLR预测胃癌免疫治疗疗效[J]. 国际肿瘤学杂志, 2024, 51(3): 157-165.
[4]	刘玉兰, 井海燕, 孙静, 宋伟, 沙丹. 胃癌免疫治疗疗效预测及预后标志物的研究进展[J]. 国际肿瘤学杂志, 2024, 51(3): 175-180.
[5]	邵慧芳, 王学红, 芦永福. CST1在胃癌进展中的作用机制及临床意义[J]. 国际肿瘤学杂志, 2023, 50(8): 489-492.
[6]	朱思雨, 王学红, 李文茜, 刘曙. 胃癌患者血清FABP1水平及其与幽门螺杆菌感染的关系[J]. 国际肿瘤学杂志, 2023, 50(6): 336-341.
[7]	杨娅, 王慧礼, 刘艳, 郭金凤, 王春霞, 吕敏, 山长平. GCSH基因在胃癌SNU-1细胞增殖和凋亡中的作用研究[J]. 国际肿瘤学杂志, 2023, 50(5): 257-262.
[8]	全祯豪, 徐飞鹏, 黄哲, 黄先进, 陈日红, 孙开裕, 胡旭, 林琳. 沉默lncRNA FTX通过miR-22-3p/NLRP3炎症体通路抑制胃癌细胞增殖[J]. 国际肿瘤学杂志, 2023, 50(4): 202-207.
[9]	姬薇, 关泉林, 陈雅蕊, 焦福智, 罗倩文. 血脂水平与胃癌的相关性[J]. 国际肿瘤学杂志, 2023, 50(3): 183-185.
[10]	范珊琳, 汪品秀, 孔飞, 周玉洁, 袁文臻. 胃癌新辅助化疗后肿瘤退缩分级预测因素的研究进展[J]. 国际肿瘤学杂志, 2023, 50(2): 112-116.
[11]	杨俊, 李荣, 曾建昌. 复方苦参注射液联合SOX方案治疗老年晚期胃癌的临床疗效[J]. 国际肿瘤学杂志, 2023, 50(2): 82-86.
[12]	邓莉莉, 段星宇, 李保中. HER2靶向药物及其联合治疗方案在胃及食管胃结合部腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2023, 50(12): 751-757.
[13]	李佳宜, 王跃, 尚兰兰, 徐兴, 赵岩. 人工智能技术在胃癌诊断与治疗中的实践与展望[J]. 国际肿瘤学杂志, 2023, 50(11): 677-682.
[14]	于晓鹏, 冯青青, 赵文飞, 赵文文, 魏红梅. 靶向治疗联合免疫检查点抑制剂在HER2阳性进展期胃癌中的应用[J]. 国际肿瘤学杂志, 2023, 50(10): 631-635.
[15]	李立立, 安有志, 王艳军. 替雷利珠单抗治疗MSI-H局部晚期胃癌患者1例[J]. 国际肿瘤学杂志, 2022, 49(7): 444-446.